0001567619-23-006677.txt : 20230726 0001567619-23-006677.hdr.sgml : 20230726 20230726115007 ACCESSION NUMBER: 0001567619-23-006677 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230726 DATE AS OF CHANGE: 20230726 EFFECTIVENESS DATE: 20230726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eterna Therapeutics Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-487908 FILM NUMBER: 231111514 BUSINESS ADDRESS: STREET 1: 1035 CAMBRIDGE STREET STREET 2: SUITE 18A CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 10531 4S COMMONS DRIVE STREET 2: SUITE 166-550 CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. DATE OF NAME CHANGE: 20210325 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 D 1 primary_doc.xml X0708 D LIVE 0000748592 Eterna Therapeutics Inc. 1035 Cambridge Street Suite 18A Cambridge MA MASSACHUSETTS 02141 (212) 582-1199 DELAWARE NTN Buzztime, Inc. Brooklyn ImmunoTherapeutics, Inc. NTN BUZZTIME INC NTN COMMUNICATIONS INC Corporation true Matthew Angel Eterna Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge MA MASSACHUSETTS 02141 Executive Officer Director President and Chief Executive Officer Sandra Gurrola Eterna Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge MA MASSACHUSETTS 02141 Executive Officer Vice President, Finance and Secretary Brant Binder Eterna Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge MA MASSACHUSETTS 02141 Director Gregory Fiore Eterna Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge MA MASSACHUSETTS 02141 Director William Wexler Eterna Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge MA MASSACHUSETTS 02141 Director Richard W. Wagner Eterna Therapeutics Inc. 1035 Cambridge Street, Suite 18A Cambridge MA MASSACHUSETTS 02141 Director Biotechnology Decline to Disclose 06b false 2023-07-14 false true true true true true 6% Senior Convertible Notes, shares of common stock, and common stock purchase warrants, including underlying common stock issuable upon conversion of Warrants and upon conversion of Notes. false 0 8715000 8715000 0 false 19 0 0 0 false Eterna Therapeutics Inc. /s/ Matthew Angel President and CEO 2023-07-25